Bankole Urges FG To Support Local Pharmaceutical Manufacturing, Says Nigeria Must Become Africa’s Pharma Hub
Posted on May 10, 2026
CYRIACUS IZUEKWE

The National Chairman of the Association of Industrial Pharmacists of Nigeria (NAIP), Pharm. (Sir) Bankole Ezebuilo, has called on the Federal Government to urgently strengthen support for local pharmaceutical manufacturing as part of efforts to reduce Nigeria’s dependence on imported medicines and position the country as the pharmaceutical hub of Africa.
P.M.EXPRESS reports that Ezebuilo made the call during the 29th Annual National Conference and Training of NAIP held in Ilorin, Kwara State.
The theme of the training is :“Collaboration and Innovation to Build Local Solutions for the Future of Nigeria’s Pharmaceutical Industry.”
Addressing pharmaceutical stakeholders, regulators, manufacturers, policymakers, and healthcare professionals at the conference, the NAIP chairman warned that no nation can afford to outsource its healthcare security.
“No nation can outsource its health security,” he declared.
He noted that Nigeria currently imports more than 70 percent of its medicines, a situation he described as dangerous to national healthcare stability and economic sustainability.
According to him, Nigeria is now at a critical crossroads where it must choose between continued dependence on imported medicines or the pursuit of pharmaceutical sovereignty through aggressive local production.
To reverse the trend, Ezebuilo urged the Federal Government to declare a national emergency on pharmaceutical manufacturing and implement policies capable of transforming Nigeria into the definitive pharmaceutical manufacturing hub in Africa.
He further assured President Bola Ahmed Tinubu that NAIP has trained and equipped its members and remains fully prepared to partner with government in driving the nation’s pharmaceutical industrial revolution.
The industrial pharmacist stressed that sustainability in healthcare delivery cannot be imported but must be deliberately built through a united ecosystem involving government, industry players, academia, development partners, and regulators.
He explained that the conference theme was carefully chosen to address the growing challenges confronting the pharmaceutical sector, especially amid global supply chain disruptions and persistent currency volatility.
“No nation can outsource its health security, and no sector can thrive in isolation,” he said, emphasizing the need for stakeholders to move beyond institutional silos.
Ezebuilo warned that a nation unable to produce its own medicines would remain vulnerable during global emergencies and healthcare crises.
“A nation that cannot produce its own medicines is a nation negotiating with its health, and negotiation is not where you want to be when lives are at stake,” he stated.
He added that heavy reliance on imported pharmaceutical products continues to weaken treatment access, expose the country to supply disruptions, and increase vulnerability during international crises.
Highlighting the need for deeper industrial reforms, Ezebuilo pointed out that although Nigeria manufactures some finished pharmaceutical products locally, the majority of Active Pharmaceutical Ingredients (APIs) are still imported.
According to him, achieving pharmaceutical self-sufficiency would stabilize medicine supply, improve quality control, create jobs, conserve foreign exchange, and position Nigeria as a strategic regional manufacturing hub.
He emphasized that bridging healthcare access gaps requires the development of a reliable local production system capable of manufacturing high-quality and compliant medicines within Nigeria.
“To build local solutions, we must stop importing not just medicines, but also ideas,” he said.








